Fecal Microbiota Transplant by Oral Capsules With Lactobacilli for Recurrent Clostridium Difficile Infection
Not Applicable
- Conditions
- Clostridium Difficile Infection
- Registration Number
- NCT03804736
- Lead Sponsor
- Universidad Autonoma de Nuevo Leon
- Brief Summary
Investigators designed an open, two-arm study to compare fecal microbiota transplant by oral capsules (FMT-c ) versus FMT-c enriched with Lactobacillus for treatment of C. difficile recurrent infection
- Detailed Description
Investigators designed an open, two-arm study to compare to compare fecal microbiota transplant by oral capsules (FMT-c ) versus FMT-c enriched with Lactobacillus for treatment of C. difficile recurrent infection.
From each patient, a fecal sample was obtained at days 0, 3, and 7 after treatment. Fecal samples are analyzed by 16 subunit ribosomal ribonucleic acid (16S rRNA) metagenomic sequencing.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Not specified
- Target Recruitment
- 21
Inclusion Criteria
- Older than 18 years With recurrent CDI
Exclusion Criteria
Older than 18 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method decrease in the number of evacuations up to two days The cure of CDI was measured
- Secondary Outcome Measures
Name Time Method